Health
Host tissue T cells play a previously unappreciated role in acute graft-versus-host disease – News-Medical.net
Allogenic hematopoietic stem cell transplantation (HSCT) is a procedure that infuses a donor’s healthy blood-forming stem cells into a recipient as part of a potentially curative therapy for cancer.
Reviewed by Emily Henderson, B.Sc.Aug 28 2020
Allogenic hematopoietic stem cell transplantation (HSCT) is a procedure that infuses a donor’s healthy blood-forming stem cells into a recipient as part of a potentially curative therapy for cancer. While this therapy can be life-saving, a major complication is the development of graft-versus-host disease (GVHD), which causes significant morbidity and can be fatal. Before allogenic HSCT, a patient receives a conditioning regimen, chemotherapy design…
-
Noosa News18 hours agoBrisbane vs Collingwood live blog: Richmond selects Noah Balta as unbeaten Lions prepare for Magpies test
-
General17 hours agoNT Coalition candidate Lisa Siebert diverges from Jacinta Nampijinpa Price on royal commission call
-
General19 hours agoCanberra man named as doctor accused of rape after suppression order lifted
-
Noosa News21 hours agoAustralians tell ABC’s Your Say how they saw the second leaders debate